Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of PRF on Dental Implant Osseointegration
NCT06037070Not yet recruiting
- Sponsor
- Al-Mustansiriyah University
- Start
- May 2024
- Primary completion
- May 2025
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Randomised, open-label trial of platelet rich fibrin in edentulism (2 arms), sponsored by Al-Mustansiriyah University. Primary endpoints: Degree of Osseointegration at 12 weeks and Bone Density in Implant Site. Planned start May 2024; status: not yet recruiting.
02
Drugs
platelet rich fibrin
03
Conditions
edentulism
Beyond the preview
Go deeper on NCT06037070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037070.